Oxford BioTherapeutics Competitors and Similar CompaniesClear all
Oxford BioTherapeutics's competitors and similar companies include Ajinomoto Bio-Pharma Services, Orchard Therapeutics, Stealth BioTherapeutics and Crossbeta Biosciences.
 Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Crossbeta Biosciences Crossbeta Biosciences is a biotech company, which develops a technology to generate stable oligomers for drug discovery and development in various disease areas. | |
Founding Date | Founding Date 2004 | Founding Date 1998 | Founding Date 2015 | Founding Date 2007 | Founding Date 2005 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Milton, GB HQ San Jose, US | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US | Locations Utrecht, NL HQ Utrecht, NL |
Employees | Employees 504% increase | Employees 68610% decrease | Employees 166 | Employees 592% decrease | Employees 2 |
Financial | |||||
Revenue (est.) | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income (£6.5m) (FY, 2018) | Net income N/A | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 21.6m | Total funding raised $ 3.5m | Total funding raised $ 310.7m | Total funding raised $ 100m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Ajinomoto Bio-Pharma Services
HQ
San Diego, US
Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).
View companyOrchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyCrossbeta Biosciences
HQ
Utrecht, NL
Employees
2
Crossbeta Biosciences is a biotech company, which develops a technology to generate stable oligomers for drug discovery and development in various disease areas.
View company